Summit Therapeutics
SMMT
#2225
Rank
NZ$15.29 B
Marketcap
NZ$19.12
Share price
-1.59%
Change (1 day)
-35.62%
Change (1 year)

EPS for Summit Therapeutics (SMMT)

EPS in 2026 (TTM): NZ-$1.87

According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$1.95. In 2025 the company made an earnings per share (EPS) of NZ-$2.64.

EPS history for Summit Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.87-29.1%
2025NZ-$2.64
2021NZ-$1.7526.32%
2020NZ-$1.38
2018NZ-$0.07905-84.63%
2017NZ-$0.51-40.59%
2016NZ-$0.876.54%
2015NZ-$0.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
NZ-$4.79 145.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
NZ$25.24-1,395.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
NZ-$1.88-3.74%๐Ÿ‡บ๐Ÿ‡ธ USA